Press coverage about Telesta Therapeutics (TSE:TST) has trended somewhat positive recently, according to InfoTrie Sentiment Analysis. The research firm scores the sentiment of press coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Telesta Therapeutics earned a coverage optimism score of 1.90 on their scale. InfoTrie also assigned press coverage about the biotechnology company an news buzz score of 8 out of 10, meaning that recent press coverage is very likely to have an effect on the stock’s share price in the next few days.
Telesta Therapeutics has a fifty-two week low of C$0.69 and a fifty-two week high of C$0.14.
About Telesta Therapeutics
Featured Story: Initial Public Offering (IPO)
Receive News & Ratings for Telesta Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Telesta Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.